Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1167703rdf:typepubmed:Citationlld:pubmed
pubmed-article:1167703lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:1167703lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:1167703lifeskim:mentionsumls-concept:C1510411lld:lifeskim
pubmed-article:1167703lifeskim:mentionsumls-concept:C0085752lld:lifeskim
pubmed-article:1167703pubmed:issue4182lld:pubmed
pubmed-article:1167703pubmed:dateCreated1975-5-21lld:pubmed
pubmed-article:1167703pubmed:abstractTextA Fischer rat embryo cell system in vitro, which had been shown to be highly accurate in identifying chemical carcinogens and to have application in the study of chemicals having anticancer properties, was used to study the anticancer drug adriamycin. At a nontoxic dose adriamycin not only did not protect the cells from transformation by the carcinogen 3-methylcholanthrene, but was found in two separate experiments to act on its own as a transforming agent.lld:pubmed
pubmed-article:1167703pubmed:languageenglld:pubmed
pubmed-article:1167703pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1167703pubmed:citationSubsetIMlld:pubmed
pubmed-article:1167703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1167703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1167703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1167703pubmed:statusMEDLINElld:pubmed
pubmed-article:1167703pubmed:monthMarlld:pubmed
pubmed-article:1167703pubmed:issn0036-8075lld:pubmed
pubmed-article:1167703pubmed:authorpubmed-author:ChirigosM AMAlld:pubmed
pubmed-article:1167703pubmed:authorpubmed-author:PriceP JPJlld:pubmed
pubmed-article:1167703pubmed:authorpubmed-author:HuebnerR JRJlld:pubmed
pubmed-article:1167703pubmed:authorpubmed-author:SukW AWAlld:pubmed
pubmed-article:1167703pubmed:authorpubmed-author:SkeenP CPClld:pubmed
pubmed-article:1167703pubmed:issnTypePrintlld:pubmed
pubmed-article:1167703pubmed:day28lld:pubmed
pubmed-article:1167703pubmed:volume187lld:pubmed
pubmed-article:1167703pubmed:ownerNLMlld:pubmed
pubmed-article:1167703pubmed:authorsCompleteYlld:pubmed
pubmed-article:1167703pubmed:pagination1200-1lld:pubmed
pubmed-article:1167703pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:1167703pubmed:meshHeadingpubmed-meshheading:1167703-...lld:pubmed
pubmed-article:1167703pubmed:meshHeadingpubmed-meshheading:1167703-...lld:pubmed
pubmed-article:1167703pubmed:meshHeadingpubmed-meshheading:1167703-...lld:pubmed
pubmed-article:1167703pubmed:meshHeadingpubmed-meshheading:1167703-...lld:pubmed
pubmed-article:1167703pubmed:meshHeadingpubmed-meshheading:1167703-...lld:pubmed
pubmed-article:1167703pubmed:meshHeadingpubmed-meshheading:1167703-...lld:pubmed
pubmed-article:1167703pubmed:meshHeadingpubmed-meshheading:1167703-...lld:pubmed
pubmed-article:1167703pubmed:meshHeadingpubmed-meshheading:1167703-...lld:pubmed
pubmed-article:1167703pubmed:year1975lld:pubmed
pubmed-article:1167703pubmed:articleTitleTransforming potential of the anticancer drug adriamycin.lld:pubmed
pubmed-article:1167703pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1167703pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed